Search research articles
Contact Us
Filters
Showing results (151-160 of 346) with videos related to
Page
of 35
Sort By:
American Journal of Hematology
|
July 24, 2023
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era
Fadi G Haddad, Koji Sasaki, Aram Bidikian, et al.
The Lancet. Haematology
|
October 24, 2022
Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial
Elias Jabbour, Nicholas J Short, Nitin Jain, et al.
Blood Cancer Journal
|
November 25, 2025
Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guide
Wei-Ying Jen, Curtis A Lachowiez, Jennifer Marvin-Peek, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 11, 2024
Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia
Nicholas J Short, Elias Jabbour, Trevor Jamison, et al.
American Journal of Hematology
|
October 30, 2021
Prediction of early (4-week) mortality in acute myeloid leukemia with intensive chemotherapy
Koji Sasaki, Tapan Kadia, Kebede Begna, et al.
Blood Cancer Journal
|
August 7, 2024
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin
Jayastu Senapati, Elias Jabbour, Nicholas J Short, et al.
American Journal of Hematology
|
January 23, 2016
Prognostic impact of persistent cytogenetic abnormalities at complete remission in adult patients with acute lymphoblastic leukemia
Nicholas J Short, Hagop M Kantarjian, Elias J Jabbour, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 15, 2020
Salvage Therapy Outcomes in a Historical Cohort of Patients With Relapsed or Refractory Acute Myeloid Leukemia
Farhad Ravandi, Sherry Pierce, Guillermo Garcia-Manero, et al.
American Journal of Hematology
|
April 13, 2019
Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts
Paolo Strati, Guillermo Garcia-Manero, Chong Zhao, et al.
British Journal of Haematology
|
June 16, 2017
A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia
Nicholas J Short, Hagop Kantarjian, Elias Jabbour, et al.
Page
of 35
Search research articles
Search
Showing results (151-160 of 346) with videos related to
Sort By:
Page
of 35
American Journal of Hematology
|
July 24, 2023
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era
Fadi G Haddad, Koji Sasaki, Aram Bidikian, et al.
The Lancet. Haematology
|
October 24, 2022
Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial
Elias Jabbour, Nicholas J Short, Nitin Jain, et al.
Blood Cancer Journal
|
November 25, 2025
Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guide
Wei-Ying Jen, Curtis A Lachowiez, Jennifer Marvin-Peek, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 11, 2024
Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia
Nicholas J Short, Elias Jabbour, Trevor Jamison, et al.
American Journal of Hematology
|
October 30, 2021
Prediction of early (4-week) mortality in acute myeloid leukemia with intensive chemotherapy
Koji Sasaki, Tapan Kadia, Kebede Begna, et al.
Blood Cancer Journal
|
August 7, 2024
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin
Jayastu Senapati, Elias Jabbour, Nicholas J Short, et al.
American Journal of Hematology
|
January 23, 2016
Prognostic impact of persistent cytogenetic abnormalities at complete remission in adult patients with acute lymphoblastic leukemia
Nicholas J Short, Hagop M Kantarjian, Elias J Jabbour, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 15, 2020
Salvage Therapy Outcomes in a Historical Cohort of Patients With Relapsed or Refractory Acute Myeloid Leukemia
Farhad Ravandi, Sherry Pierce, Guillermo Garcia-Manero, et al.
American Journal of Hematology
|
April 13, 2019
Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts
Paolo Strati, Guillermo Garcia-Manero, Chong Zhao, et al.
British Journal of Haematology
|
June 16, 2017
A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia
Nicholas J Short, Hagop Kantarjian, Elias Jabbour, et al.
Page
of 35